| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada (BJH), and the Section of Nutritional Neuroscience, Laboratory of Membrane Biochemistry and Biophysics, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD (KDS).
Background: Dietary docosahexaenoic acid (DHA) has triacylglycerol-lowering potential and undergoes in vivo retroconversion to eicosapentaenoic acid (EPA) in humans. Hormone replacement therapy (HRT) influences circulating lipid concentrations and fatty acid metabolism. DHA supplementation has not been studied in postmenopausal women.
Objective: We studied the effects of supplementation with DHA (free of EPA) on the resulting elevation in EPA and on selected cardiovascular disease risk factors in postmenopausal women.
Design: Women receiving (n = 18) and not receiving (n = 14) HRT completed a randomized, double-blind, placebo-controlled crossover trial with a DHA supplement (2.8 g DHA/d). A washout period of 
6 wk divided the two 28-d intervention periods. Fasting blood samples were collected for analysis.
Results: In all women, DHA supplementation was associated with significant changes (P < 0.05), including 20% lower serum triacylglycerol concentrations, 8% higher HDL-cholesterol concentrations, a 28% lower overall ratio of serum triacylglycerol to HDL cholesterol, and a 7% decrease in resting heart rate. DHA supplementation resulted in a 45% lower net increase (P = 0.02) in EPA and a 42% lower (P = 0.0028) estimated percentage retroconversion of DHA to EPA [
EPA/(EPA + DHA) x 100] in women receiving than in those not receiving HRT.
Conclusion: With DHA supplementation, the accumulation of EPA in serum phospholipids is significantly attenuated in postmenopausal women receiving HRT compared with that in women not receiving HRT. DHA supplementation can also favorably influence selected cardiovascular disease risk factors in postmenopausal women.
Key Words: Fish oil • n–3 fatty acids • docosahexaenoic acid • DHA • total cholesterol • LDL cholesterol • HDL cholesterol • triacylglycerol • postmenopausal women • hormone replacement therapy • cardiovascular disease • retroconversion • heart rate • C-reactive protein
This article has been cited by other articles:
|
|
 |
|
  H. E. C. Hanwell, C. D. Kay, J. W. Lampe, B. J. Holub, and A. M. Duncan Acute Fish Oil and Soy Isoflavone Supplementation Increase Postprandial Serum (n-3) Polyunsaturated Fatty Acids and Isoflavones but Do Not Affect Triacylglycerols or Biomarkers of Oxidative Stress in Overweight and Obese Hypertriglyceridemic Men J. Nutr., June 1, 2009; 139(6): 1128 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Patterson and K. D. Stark Direct Determinations of the Fatty Acid Composition of Daily Dietary Intakes Incorporating Nutraceuticals and Functional Food Strategies to Increase n-3 Highly Unsaturated Fatty Acids J. Am. Coll. Nutr., October 1, 2008; 27(5): 538 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rudkowska Functional foods for cardiovascular disease in women Menopause Int, June 1, 2008; 14(2): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Kelley, D. Siegel, M. Vemuri, G. H. Chung, and B. E. Mackey Docosahexaenoic Acid Supplementation Decreases Remnant-Like Particle-Cholesterol and Increases the (n-3) Index in Hypertriglyceridemic Men J. Nutr., January 1, 2008; 138(1): 30 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Laurent, G. Moe, X. Hu, B. Holub, H. Leong-Poi, J. Trogadis, K. Connelly, D. Courtman, B. H. Strauss, and P. Dorian Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model Cardiovasc Res, January 1, 2008; 77(1): 89 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Stark, S.-Y. Lim, and N. Salem Jr. Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid composition J. Lipid Res., November 1, 2007; 48(11): 2471 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S Kelley, D. Siegel, M. Vemuri, and B. E Mackey Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men Am. J. Clinical Nutrition, August 1, 2007; 86(2): 324 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M Arterburn, E. B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1467 - 1476S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials Circulation, September 27, 2005; 112(13): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Maki, M. E. Van Elswyk, D. McCarthy, S. P. Hess, P. E. Veith, M. Bell, P. Subbaiah, and M. H. Davidson Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol J. Am. Coll. Nutr., June 1, 2005; 24(3): 189 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Stark, S. Beblo, M. Murthy, M. Buda-Abela, J. Janisse, H. Rockett, J. E. Whitty, S. S. Martier, R. J. Sokol, J. H. Hannigan, et al. Comparison of bloodstream fatty acid composition from African-American women at gestation, delivery, and postpartum J. Lipid Res., March 1, 2005; 46(3): 516 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Denomme, K. D. Stark, and B. J. Holub Directly Quantitated Dietary (n-3) Fatty Acid Intakes of Pregnant Canadian Women Are Lower than Current Dietary Recommendations J. Nutr., February 1, 2005; 135(2): 206 - 211. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
